Profile data is unavailable for this security.
About the company
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)1.82bn
- Net income in CNY339.81m
- Incorporated2008
- Employees1.76k
- LocationShenzhen YHLO Biotech Co LtdNo. 65, Baolong 2nd RoadBaolong Neighbourhood, Longgang DistrictSHENZHEN 518116ChinaCHN
- Phone+86 75 526473359
- Fax+86 75 526473319
- Websitehttps://www.szyhlo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Wandong Medical Technolgy Co Ltd | 1.29bn | 191.36m | 10.69bn | 1.06k | 55.91 | 2.25 | -- | 8.28 | 0.2719 | 0.2719 | 1.83 | 6.75 | 0.2444 | 2.33 | 4.28 | 1,218,206.00 | 3.70 | 5.30 | 4.12 | 6.21 | 40.81 | 45.21 | 15.14 | 16.46 | 10.29 | -- | 0.0144 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shinva Medical Instrument Co Ltd | 10.10bn | 668.52m | 11.01bn | 8.21k | 16.42 | 1.46 | -- | 1.09 | 1.44 | 1.44 | 21.62 | 16.18 | 0.6785 | 2.22 | 5.36 | 1,230,542.00 | 4.63 | 4.63 | 9.18 | 10.76 | 26.22 | 24.22 | 6.83 | 6.12 | 0.7893 | -- | 0.176 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Shanghai Microport EP MedTech Co Ltd | 366.21m | 19.18m | 12.12bn | 577.00 | 631.59 | 7.17 | -- | 33.09 | 0.0408 | 0.0408 | 0.7782 | 3.59 | 0.2013 | 1.18 | 9.01 | 634,687.40 | 1.05 | -- | 1.11 | -- | 61.35 | -- | 5.24 | -- | 12.39 | -- | 0.014 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Micro-Tech Nanjing Co Ltd | 2.48bn | 527.90m | 13.87bn | 2.40k | 26.25 | 3.72 | -- | 5.59 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.82bn | 339.81m | 14.40bn | 1.76k | 42.55 | 5.48 | -- | 7.89 | 0.5956 | 0.5956 | 3.21 | 4.62 | 0.4798 | 1.11 | 4.91 | 1,037,196.00 | 7.03 | 16.43 | 9.12 | 24.16 | 62.14 | 53.26 | 14.66 | 20.01 | 1.50 | -- | 0.1872 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.26bn | 551.89m | 15.62bn | 908.00 | 25.83 | 3.86 | -- | 12.40 | 7.31 | 7.31 | 16.80 | 48.87 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Beijing Balance Medical Technolgy Co Ltd | 382.01m | 111.83m | 15.73bn | 473.00 | 141.92 | 13.03 | -- | 41.18 | 0.8115 | 0.8115 | 2.77 | 8.84 | 0.3061 | 1.06 | 5.72 | 807,636.20 | 8.16 | 8.06 | 8.48 | 8.40 | 89.40 | 89.41 | 26.67 | 30.02 | 9.77 | -- | 0.0094 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
| Eyebright Medical Tchnlgy Beijing Co Ltd | 1.07bn | 328.48m | 16.63bn | 2.07k | 50.72 | 7.51 | -- | 15.52 | 3.12 | 3.12 | 10.16 | 21.05 | 0.4003 | 1.99 | 5.19 | 516,774.60 | 11.51 | 9.99 | 13.27 | 11.16 | 72.24 | 81.29 | 28.74 | 34.66 | 2.48 | -- | 0.1339 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
Data as of Mar 13 2024. Currency figures normalised to Shenzhen YHLO Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 8.13m | 3.04% |
| Changsheng Fund Management Co., Ltd.as of 30 Jun 2023 | 6.42m | 2.40% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2023 | 6.23m | 2.33% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 5.23m | 1.95% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.83m | 1.43% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2023 | 2.00m | 0.75% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.43m | 0.53% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 953.83k | 0.36% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2023 | 940.17k | 0.35% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 923.09k | 0.35% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
